SHREE GANESH REMEDIES LTD Share Price

₹ 620.00

+₹21.15 (3.53%)
1D
Last updated 03 Nov, 2026, 15:29 IST
NSE: SGRL
|
Pharmaceuticals

SHREE GANESH REMEDIES LTD Share Price Today

As of 3 Nov 2026, SHREE GANESH REMEDIES LTD share price is ₹620.00. The stock opened at ₹598.85, compared to its previous close of ₹598.85. During today's trading session, SHREE GANESH REMEDIES LTD share price moved in the range of ₹589.95 to ₹632.45, with an average price of ₹611.20 for the day. Looking at its last 52-week, the stock has touched a low of ₹477.05 and a high of ₹749.85. On the performance front, SHREE GANESH REMEDIES LTD share price has declined by 12.49% over the last six months and is down 12.49% on a year-on-year basis.

Share price over the last 1 day rose from 589.95 to 620.00, ranging between 589.95 and 632.45.
₹589.95
3.53% up today
₹632.45
1D LOW
1D HIGH

SHREE GANESH REMEDIES LTD Stock Insights

Latest Earning
Op Profit TrendUp by 47.71% QoQ
Latest Earning
Net Profit TrendUp by 45.54% QoQ
Latest Earning
Revenue TrendUp by 61.44% QoQ
Stock Performance
OutperformingBeat Nifty by 16.29 % in last 3 month
Shareholding Pattern
DIIDII increased stake by 89.83%
SHREE GANESH REMEDIES LTD stock performance
Open₹598.85
High₹632.45
Low₹589.95
Prev. close₹598.85
SHREE GANESH REMEDIES LTD trading activity
Volume7,441
Average traded price₹618.96
Last traded time03:29:46 03 Nov
Last traded quantity10
Circuit
L
H
₹479.10
₹718.60
52-week
L
H
₹477.05
₹749.85
Mkt Cap Cr
792.08
P/E
63.38
P/B
4.63
ROA
7.34%
ROE
10.9%
ROCE
14.23%
Quick Ratio
2.85
EV/EBITDA
23.55

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Shree Ganesh Rem has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Shree Ganesh Rem appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Shree Ganesh Rem earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4826.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SHREE GANESH REMEDIES LTD Company Background

ISIN
INE414Y01015
Sector Market Cap
₹ 792.08 Cr

Shree Ganesh Remedies Limited is an India-based company, which is engaged in the business of bulk drug intermediates. The Company's products include intermediates by active pharmaceutical ingredient (API), and fine and specialty chemicals. Its human health API intermediates include antipsychotic, antidepression, oncology, diabetic, and diuretic. Its specialty & fine chemicals include aroma & health industry, agro-industry, polymer industry, and electronics industry. Its veterinary API intermediates include feed additives, antiparasitic, and anti-inflammatory. Its anti-arrhythmic API intermediates include amiodarone intermediates, dronedarone intermediates, and mesalazine intermediates. Its anti-cancer API intermediates include cabozantinib intermediates, gefitinib intermediates, olaparib intermediates, and raloxifene intermediates. Its anti-parasitic API intermediates include flubendazole intermediates, nitazoxanide intermediates, and praziquantel intermediates.

SHREE GANESH REMEDIES LTD Financial Highlights

  • Revenue: SHREE GANESH REMEDIES LTD reported revenue of ₹112.32 crore in FY26 vs ₹112.33 crore in FY25. It showed a decrease of 0.01% on a yearly basis.
  • Operating Profit: SHREE GANESH REMEDIES LTD reported an operating profit of ₹24.01 crore in FY26 vs ₹31.27 crore in FY25. It showed a decrease of 23.22% on a year-on-year basis.
  • Net Profit: SHREE GANESH REMEDIES LTD reported a net profit of ₹17.76 crore in FY26 vs ₹23.07 crore in FY25. It showed a decrease of 23.02% on a yearly basis.

SHREE GANESH REMEDIES LTD Quarterly Result Highlights

  • SHREE GANESH REMEDIES LTD reported revenue of ₹24.70 crore in Sep 2026, compared with ₹15.30 crore in Jun 2026, representing an increase of 61.44% on a quarter-on-quarter (QoQ) basis.
  • SHREE GANESH REMEDIES LTD reported an operating profit of ₹2.26 crore in Sep 2026, compared with ₹1.53 crore in Jun 2026, representing an increase of 47.71% on a quarter-on-quarter (QoQ) basis.
  • SHREE GANESH REMEDIES LTD reported a profit of ₹1.63 crore in Sep 2026, compared with ₹1.12 crore in Jun 2026, reflecting an increase of 45.54% on a QoQ basis.
  • The earnings per share (EPS) of SHREE GANESH REMEDIES LTD stood at ₹13.83 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
72.84%
FII
0.00%
Other DII
0.99%
Retail and other
26.17%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

SHREE GANESH REMEDIES LTD Investment Returns

1 day
-2.98%
1 week
-5.40%
1 month
-13.74%
1 year
-12.49%
3 years
-12.49%
5 years
-12.49%

SHREE GANESH REMEDIES LTD Share Price History

SHREE GANESH REMEDIES LTD share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹606.00 / ₹598.85
-2.98%
30 Oct 26
₹639.75 / ₹617.25
-3.52%
29 Oct 26
₹677.00 / ₹639.75
-2.77%
28 Oct 26
₹662.00 / ₹658.00
-0.62%
Show more

SHREE GANESH REMEDIES LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2020
Revenue₹109.29₹108.60₹125.90₹64.02
Other Income₹3.03₹3.73₹3.07₹3.91
Total Revenue₹112.32₹112.33₹128.97₹67.93
Total Expenses₹88.30₹81.06₹90.81₹54.34
Profit Before Tax₹24.01₹31.27₹38.16₹13.59
Tax₹6.26₹8.20₹10.05₹3.12
Profit After Tax₹17.76₹23.07₹28.11₹10.47
EPS - Basic₹13.83₹17.96₹22.34₹11.67
EPS - Diluted₹13.83₹17.96₹22.34₹11.67

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2020
Profit before tax₹24.01₹31.27₹38.16₹10.47
Income before WC changes₹35.64₹42.45₹44.05₹9.93
Change in Assets-₹11.03₹0.46₹1.41-₹9.82
Change in Liabilities₹3.96-₹2.19-₹6.88₹4.48
Change in WC-₹7.07-₹1.73-₹5.47-₹5.34
Cash flow from Operations₹23.74₹30.66₹30.45₹4.59
Cash flow from Investing-₹9.89-₹35.66-₹33.01-₹2.91
Cash flow from Financing-₹11.70-₹1.09₹9.84-₹0.48
Total Cash Flow₹2.16-₹6.08₹7.28₹1.20
Cash (Start of the year)₹9.95₹15.85₹8.66₹1.13
Cash (End of the year)₹13.40₹9.95₹15.85₹2.33

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2020
Non-Current Assets₹121.82₹114.37₹100.73₹21.46
Current Assets₹85.86₹77.58₹70.20₹33.82
Total Assets₹207.69₹191.94₹170.94₹55.28
Current Liabilities₹21.69₹16.18₹18.68₹10.38
Net Current Asset₹64.17₹61.39₹51.52₹23.44
Non-Current Liabilities₹23.03₹30.60₹30.16₹2.65
Equity Capital₹162.97₹145.16₹122.10₹42.25
Total Equity & Liabilities₹207.69₹191.94₹170.94₹55.28

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹109.29₹108.60₹125.90₹91.36
Other Income₹3.03₹3.73₹3.07₹0.72
Total Revenue₹112.32₹112.33₹128.97₹92.07
Total Expenses₹88.30₹81.03₹90.80₹71.84
Profit Before Tax₹24.01₹31.30₹38.17₹20.24
Tax₹6.24₹8.20₹10.05₹5.05
Profit After Tax₹17.77₹23.10₹28.12₹15.18
EPS - Basic₹13.84₹17.98₹22.35₹12.54
EPS - Diluted₹13.84₹17.98₹22.35₹12.54

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹24.01₹31.30₹38.17₹20.24
Income before WC changes₹35.63₹42.45₹44.05₹26.72
Change in Assets-₹11.03₹0.46₹1.41-₹11.23
Change in Liabilities₹3.96-₹2.19-₹6.88₹1.61
Change in WC-₹7.07-₹1.73-₹5.47-₹9.62
Cash flow from Operations₹23.75₹30.66₹30.45₹17.10
Cash flow from Investing-₹9.89-₹35.66-₹33.09-₹51.09
Cash flow from Financing-₹11.70-₹1.06₹9.85₹38.66
Total Cash Flow₹2.17-₹6.05₹7.21₹4.67
Cash (Start of the year)₹9.90₹15.78₹8.66₹3.88
Cash (End of the year)₹13.36₹9.90₹15.78₹8.66

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹121.91₹114.45₹100.82₹75.75
Current Assets₹85.83₹77.53₹70.13₹62.22
Total Assets₹207.74₹191.98₹170.94₹137.97
Current Liabilities₹21.69₹16.18₹18.68₹20.11
Net Current Asset₹64.14₹61.35₹51.45₹42.11
Non-Current Liabilities₹23.03₹30.60₹30.16₹30.66
Equity Capital₹163.02₹145.19₹122.11₹87.20
Total Equity & Liabilities₹207.74₹191.98₹170.94₹137.97
* All values are in INR Crore
SHREE GANESH REMEDIES LTD market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
SHREE GANESH REMEDIES LTD technical summary
Bearish indicators2
Neutral indicators4
Bullish indicators2
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
39.74
Neutral
ATR (14)
38.04
Neutral
STOCH(9,6)
23.37
Neutral
STOCH RSI (14)
0
Bullish
ADX(9)
23.64
Bearish
UO(9)
38.25
Neutral
ROC(12)
-10.06
Bearish
WillR(14)
-80.01
Bullish
Period
Simple value
Exponential vaue
5D
635.19
625.38
10D
643.1
640.2
20D
666.25
655.04
50D
651.8
637.3
100D
644.71
0
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

SHREE GANESH REMEDIES LTD
Pharmaceuticals
Add Stock
Add Another

SHREE GANESH REMEDIES LTD Returns Calculator

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

SHREE GANESH REMEDIES LTD Share Price FAQs

Please be aware that SHREE GANESH REMEDIES LTD stock prices are subject to continuous fluctuations due to various factors.